Back to Search Start Over

Encrypted federated learning for secure decentralized collaboration in cancer image analysis.

Authors :
Truhn D
Tayebi Arasteh S
Saldanha OL
Müller-Franzes G
Khader F
Quirke P
West NP
Gray R
Hutchins GGA
James JA
Loughrey MB
Salto-Tellez M
Brenner H
Brobeil A
Yuan T
Chang-Claude J
Hoffmeister M
Foersch S
Han T
Keil S
Schulze-Hagen M
Isfort P
Bruners P
Kaissis G
Kuhl C
Nebelung S
Kather JN
Source :
Medical image analysis [Med Image Anal] 2024 Feb; Vol. 92, pp. 103059. Date of Electronic Publication: 2023 Dec 07.
Publication Year :
2024

Abstract

Artificial intelligence (AI) has a multitude of applications in cancer research and oncology. However, the training of AI systems is impeded by the limited availability of large datasets due to data protection requirements and other regulatory obstacles. Federated and swarm learning represent possible solutions to this problem by collaboratively training AI models while avoiding data transfer. However, in these decentralized methods, weight updates are still transferred to the aggregation server for merging the models. This leaves the possibility for a breach of data privacy, for example by model inversion or membership inference attacks by untrusted servers. Somewhat-homomorphically-encrypted federated learning (SHEFL) is a solution to this problem because only encrypted weights are transferred, and model updates are performed in the encrypted space. Here, we demonstrate the first successful implementation of SHEFL in a range of clinically relevant tasks in cancer image analysis on multicentric datasets in radiology and histopathology. We show that SHEFL enables the training of AI models which outperform locally trained models and perform on par with models which are centrally trained. In the future, SHEFL can enable multiple institutions to co-train AI models without forsaking data governance and without ever transmitting any decryptable data to untrusted servers.<br />Competing Interests: Declaration of Competing Interest The Authors declare no competing financial or non-financial interests. For transparency, we provide the following information: JNK declares consulting services for Owkin, France, DoMore Diagnostics, Norway, Panakeia, UK, Scailyte, Switzerland, Cancilico, Germany, Mindpeak, Germany, and Histofy, UK; furthermore he holds shares in StratifAI GmbH, Germany, and has received honoraria for lectures by AstraZeneca, Bayer, Eisai, MSD, BMS, Roche, Pfizer and Fresenius. DT holds shares in StraifAI GmbH, Germany and received honoraria for lectures by Bayer. PQ and NW declare research funding from Roche and PQ consulting and speaker services for Roche. MST has recently received honoraria for advisory work in relation to the following companies: Incyte, MindPeak, MSD, BMS and Sonrai; these are all unrelated to this work. No other potential conflicts of interest are reported by any of the authors. The authors received advice from NVIDIA when performing this study, but NVIDIA did not have any role in study design, conducting the experiments, interpretation of the results or decision to submit for publication.<br /> (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1361-8423
Volume :
92
Database :
MEDLINE
Journal :
Medical image analysis
Publication Type :
Academic Journal
Accession number :
38104402
Full Text :
https://doi.org/10.1016/j.media.2023.103059